IOBT has 36-month beta value of 0.37. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for IOBT is 48.45M, and currently, short sellers hold a 0.35% ratio of that float. The average trading volume of IOBT on June 03, 2025 was 162.68K shares.
IOBT) stock’s latest price update
IO Biotech Inc (NASDAQ: IOBT)’s stock price has gone rise by 14.08 in comparison to its previous close of 1.42, however, the company has experienced a 33.88% increase in its stock price over the last five trading days. zacks.com reported 2025-05-28 that After reaching an important support level, IO Biotech, Inc. (IOBT) could be a good stock pick from a technical perspective. IOBT recently experienced a “golden cross” event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
IOBT’s Market Performance
IO Biotech Inc (IOBT) has seen a 33.88% rise in stock performance for the week, with a 60.40% gain in the past month and a 87.65% surge in the past quarter. The volatility ratio for the week is 6.89%, and the volatility levels for the past 30 days are at 6.57% for IOBT. The simple moving average for the past 20 days is 44.87% for IOBT’s stock, with a 59.17% simple moving average for the past 200 days.
IOBT Trading at 57.14% from the 50-Day Moving Average
After a stumble in the market that brought IOBT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.36% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IOBT starting from Hunter Heidi, who purchase 15,000 shares at the price of $1.39 back on May 30 ’25. After this action, Hunter Heidi now owns 15,000 shares of IO Biotech Inc, valued at $20,884 using the latest closing price.
Ahmad Qasim Iftikhar, the Chief Medical Officer of IO Biotech Inc, purchase 31,350 shares at $0.85 during a trade that took place back on Dec 23 ’24, which means that Ahmad Qasim Iftikhar is holding 31,350 shares at $26,553 based on the most recent closing price.
Stock Fundamentals for IOBT
The total capital return value is set at -3.55. Equity return is now at value -138.78, with -113.23 for asset returns.
Based on IO Biotech Inc (IOBT), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -45.65.
Currently, EBITDA for the company is -93.2 million with net debt to EBITDA at 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.32.
Conclusion
To put it simply, IO Biotech Inc (IOBT) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
